Insights on the Germany Breast Cancer Diagnostics and Therapeutics Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025

Germany breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.3% during the forecast period. Increasing the incidence of breast cancer coupled with a growing awareness program towrds breast cancer diagnosis and treatment are the major factors that contributing to the growth of the market. According to the WHO, in 2018 there were 71,888 new cases of breast cancer in Germany. The growing cases of breast cancer in the country further propels thed demand for diagnostics and further treatment facilities for breast cancer thus contributing to the market growth. The statutory early detection program offers women above 30 years of age an annual palpation examination by a physician. According to the quality assured Mammography Screening Program in Germany, and women between 50 and 69 years of age are invited to an X-ray examination of the breasts every two years.

To Request a Sample of our Report on Germany Breast Cancer Diagnostics and Therapeutics Market: https://www.omrglobal.com/request-sample/germany-breast-cancer-diagnostics-therapeutics-market

Germany breast cancer diagnosis and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others.

(Get 15% Discount on Buying this Report)

A full Report of Germany Breast Cancer Diagnostics and Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/germany-breast-cancer-diagnostics-therapeutics-market

Germany Breast Cancer Diagnostics and Therapeutics Market Segmentation

By Cancer Type

· Ductal Carcinoma In-Situ (DCIS)

· Invasive Ductal Carcinoma (IDC)

· Triple Negative Breast Cancer (TNBC)

· Inflammatory Breast Cancer

· Others (Invasive lobular carcinoma)

By Diagnostics

· Mammography

· Biopsy

· PET/CET

· Ultrasound

· Others (MRI)

By Therapeutics

· Chemotherapy

· Hormone Therapy

· Targeted Therapy

· Others (Radiation Therapy, Surgery)

Company Profiles

· Agendia NV

· AstraZeneca PLC

· Bayer AG

· GlaxoSmithKline PLC

· Mylan NV

· Merck & Co., Inc.

· Novartis International AG

· F. Hoffmann-La Roche AG

· Sanofi S.A.

· Siemens Healthcare GmbH

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.